MEDA
ORG:MEDANTA
Medanta - The Medicity
- Stock
Last Close
1,113.65
25/11 09:40
Market Cap
334.78B
Beta: -
Volume Today
127.50K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|
average inventory | 391.39M - | 465.74M 19.00% | 568.79M 22.13% | 636.10M 11.83% | |||
average payables | 1.31B - | 1.33B 1.37% | 1.65B 23.75% | 1.91B 15.94% | |||
average receivables | 1.21B - | 2.18B 80.12% | 1.18B 45.92% | ||||
book value per share | 52.03 - | 53.93 3.64% | 54.98 1.96% | 64.09 16.55% | 93.68 46.18% | 108.17 15.47% | |
capex per share | -12.04 - | -7.52 37.50% | -5.80 22.94% | -10.88 87.77% | -9.10 16.36% | 10.37 213.92% | |
capex to depreciation | -2.95 - | -1.64 44.52% | -1.18 27.72% | -2.12 78.90% | -1.57 25.61% | 1.61 202.46% | |
capex to operating cash flow | -1.94 - | -1.08 44.61% | -0.60 43.95% | -0.88 46.29% | -0.37 58.48% | 0.46 224.31% | |
capex to revenue | -0.21 - | -0.13 38.93% | -0.10 19.78% | -0.13 24.97% | -0.09 31.20% | 0.09 197.11% | |
cash per share | 10.70 - | 9.99 6.61% | 11.51 15.13% | 20.30 76.38% | 50.57 149.15% | 43.04 14.89% | |
days of inventory on hand | 8.71 - | 43.28 397.01% | 41.63 3.81% | 35.89 13.79% | 35.24 1.81% | 15.66 55.57% | |
days payables outstanding | 44.25 - | 146.91 232.01% | 137.76 6.23% | 90.31 34.44% | 113.65 25.85% | 43.75 61.51% | |
days sales outstanding | 48.39 - | 41.03 - | 26.31 35.88% | 26.31 0.02% | |||
debt to assets | 0.22 - | 0.35 58.22% | 0.35 0.77% | 0.35 1.98% | 0.27 22.68% | 0.10 64.26% | |
debt to equity | 0.42 - | 0.69 63.66% | 0.67 2.11% | 0.69 1.85% | 0.46 32.67% | 0.14 68.77% | |
dividend yield | |||||||
earnings yield | 0.00 - | 0.00 29.55% | 0.00 21.07% | 0.02 579.10% | 0.02 27.07% | 0.01 43.98% | |
enterprise value | 110.38B - | 111.46B 0.97% | 112.74B 1.15% | 114.33B 1.41% | 140.13B 22.57% | 361.36B 157.86% | |
enterprise value over ebitda | 63.43 - | 46.23 27.11% | 48.17 4.19% | 23.21 51.82% | 20.47 11.81% | 41.45 102.53% | |
ev to operating cash flow | 71.51 - | 63.67 10.96% | 46.63 26.76% | 36.73 21.23% | 21.74 40.80% | 59.04 171.53% | |
ev to sales | 7.66 - | 7.52 1.84% | 7.88 4.82% | 5.30 32.71% | 5.20 1.92% | 11.03 112.13% | |
free cash flow per share | -5.84 - | -0.53 90.96% | 3.82 824.18% | 1.46 61.81% | 15.76 980.36% | 12.42 21.22% | |
free cash flow yield | -0.01 - | -0.00 90.96% | 0.01 824.18% | 0.00 61.81% | 0.03 749.10% | 0.01 68.82% | |
graham net net | -28.97 - | -41.85 44.46% | -39.88 4.72% | -32.09 19.53% | -7.76 75.82% | -1.19 84.72% | |
graham number | 49.11 - | 41.97 14.55% | 37.65 10.29% | 105.92 181.34% | 162.84 53.73% | 208.16 27.83% | |
income quality | 3.01 - | 2.74 8.93% | 7.45 171.78% | 1.11 85.10% | 1.43 29.30% | 1.28 10.77% | |
intangibles to total assets | 0.00 - | 0.00 474.57% | 0.00 15.47% | 0.00 25.90% | 0.00 36.99% | 0.00 2.57% | |
interest coverage | 1.01 - | 2.47 144.39% | 1.65 33.19% | 4.60 178.31% | 6.86 49.32% | 16.14 135.19% | |
interest debt per share | 24.76 - | 39.16 58.15% | 39.72 1.43% | 47.11 18.61% | 46.29 1.73% | 18.31 60.44% | |
inventory turnover | 41.91 - | 8.43 79.88% | 8.77 3.96% | 10.17 16.00% | 10.36 1.85% | 23.31 125.08% | |
invested capital | 0.42 - | 0.69 63.66% | 0.67 2.11% | 0.69 1.85% | 0.46 32.67% | 35.14B 7,606,207,815,968.23% | |
market cap | 103.12B - | 103.64B 0.51% | 104.12B 0.46% | 104.43B 0.30% | 136.59B 30.79% | 357.58B 161.80% | |
net current asset value | -6.55B - | -8.38B 27.97% | -8.10B 3.40% | -7.18B 11.34% | -1.08B 84.92% | 1.10B 201.83% | |
net debt to ebitda | 4.17 - | 3.24 22.36% | 3.68 13.63% | 2.01 45.46% | 0.52 74.21% | 0.43 16.46% | |
net income per share | 2.06 - | 1.45 29.55% | 1.15 21.07% | 7.78 579.10% | 12.58 61.68% | 17.80 41.52% | |
operating cash flow per share | 6.20 - | 7.00 12.83% | 9.62 37.47% | 12.34 28.36% | 24.87 101.44% | 22.79 8.36% | |
payables turnover | 8.25 - | 2.48 69.88% | 2.65 6.64% | 4.04 52.54% | 3.21 20.54% | 8.34 159.79% | |
receivables turnover | 7.54 - | 8.90 - | 13.87 55.97% | 13.87 0.02% | |||
research and ddevelopement to revenue | 0.00 - | 0.00 61.11% | 0.00 133.15% | 0.00 45.00% | 0.00 - | ||
return on tangible assets | 0.02 - | 0.01 34.11% | 0.01 21.56% | 0.06 482.98% | 0.08 26.92% | 0.11 40.24% | |
revenue per share | 57.88 - | 59.24 2.34% | 56.90 3.94% | 85.50 50.25% | 103.94 21.57% | 121.93 17.30% | |
roe | 0.04 - | 0.03 32.03% | 0.02 22.59% | 0.12 482.65% | 0.13 10.61% | 0.16 22.55% | |
roic | 0.02 - | 0.03 29.33% | 0.04 36.37% | 0.08 124.03% | 0.10 19.63% | 0.27 164.91% | |
sales general and administrative to revenue | 0.02 - | 0.02 15.79% | 0.02 14.24% | 0.12 471.77% | 0.15 23.98% | ||
shareholders equity per share | 52.03 - | 53.93 3.64% | 54.98 1.96% | 64.09 16.55% | 93.68 46.18% | 108.17 15.47% | |
stock based compensation to revenue | 0.01 - | 0.00 58.97% | 0.00 69.56% | 0.00 - | |||
tangible asset value | 13.30B - | 13.41B 0.87% | 13.75B 2.54% | 16.10B 17.06% | 24.23B 50.52% | 29.00B 19.69% | |
tangible book value per share | 53.40 - | 53.59 0.36% | 54.70 2.07% | 63.84 16.71% | 93.68 46.75% | 107.97 15.25% | |
working capital | 1.93B - | 1.21B 37.26% | 974.70M 19.40% | 3.92B 302.43% | 10.07B 156.71% | 8.91B 11.51% |
All numbers in INR (except ratios and percentages)